Get the Stockscreener App
7.11
1.39%
-0.10
Exagen Inc stock is traded at $7.11, with a volume of 225.03K.
It is down -1.39% in the last 24 hours and down -25.86% over the past month.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
See More
Previous Close:
$7.21
Open:
$7.19
24h Volume:
225.03K
Relative Volume:
0.71
Market Cap:
$161.13M
Revenue:
$52.55M
Net Income/Loss:
$-23.69M
P/E Ratio:
-7.5638
EPS:
-0.94
Net Cash Flow:
$-15.29M
1W Performance:
-1.25%
1M Performance:
-25.86%
6M Performance:
+1.86%
1Y Performance:
+24.08%
1-Day Range:
$7.03
$7.29
1-Week Range:
$6.94
$7.355
52-Week Range:
$2.76
$12.23
Exagen Inc Stock (XGN) Company Profile
Name
Exagen Inc
Sector
Industry
Phone
(760) 560-1501
Address
1261 LIBERTY WAY, VISTA, CA
Compare XGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
7.11 | 163.40M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
572.28 | 217.50B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.33 | 164.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
704.20 | 56.49B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
139.68 | 40.44B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.26 | 38.48B | 15.90B | 1.28B | 2.21B | 7.2842 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-11-25 | Initiated | B. Riley Securities | Buy |
| Jul-30-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-23-25 | Initiated | Craig Hallum | Buy |
| Aug-05-22 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Apr-15-21 | Initiated | Canaccord Genuity | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Jun-02-20 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-14-19 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-14-19 | Initiated | Cowen | Outperform |
| Oct-14-19 | Initiated | William Blair | Outperform |
View All
Exagen Inc Stock (XGN) Latest News
What New Catalysts Are Shaping the Narrative for Exagen? - Yahoo Finance
Comparing Fonar (NASDAQ:FONR) & Exagen (NASDAQ:XGN) - Defense World
Reviewing MacroGenics (NASDAQ:MGNX) & Exagen (NASDAQ:XGN) - Defense World
Will Exagen Inc. stock maintain dividend yield2025 Institutional Moves & Fast Exit and Entry Strategy Plans - Newser
Why Exagen Inc. (E08A) stock stays resilientWatch List & Daily Entry Point Trade Alerts - Newser
Is Exagen Inc. (E08A) stock good for wealth creationWeekly Trend Report & Daily Chart Pattern Signals - Newser
Is Exagen Inc. (E08A) stock protected from inflationTrade Volume Report & Free Technical Confirmation Trade Alerts - Newser
How Exagen Inc. (E08A) stock correlates with oil marketsQuarterly Profit Report & Expert Approved Momentum Trade Ideas - Newser
How higher bond yields impact Exagen Inc. (E08A) stockQuarterly Earnings Summary & Safe Entry Zone Identification - Newser
Is Exagen Inc. (E08A) stock supported by strong fundamentalsWeekly Trade Review & Verified Short-Term Plans - Newser
Exagen continues to execute on re-acceleration strategy, says Canaccord - TipRanks
Is Exagen Inc E08A a good long term investmentStock Market Trends & Free Realize Exceptional Returns - earlytimes.in
Exagen price target raised to $18 from $15 at B. Riley - MSN
What Wall Street predicts for Exagen Inc. stock price2025 Volatility Report & Low Risk Investment Opportunities - BỘ NỘI VỤ
Exagen Inc. (NASDAQ:XGN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Why Analysts Are Updating Exagen’s Story After Higher Targets and Growth Outlook - Yahoo Finance
Is Exagen Inc. (E08A) stock a momentum leaderMarket Sentiment Summary & Safe Entry Zone Tips - newser.com
Will Exagen Inc. stock split attract more investors2025 Growth vs Value & Daily Stock Trend Reports - newser.com
Is Exagen Inc. stock a contrarian buyProfit Target & Daily Oversold Stock Bounce Ideas - newser.com
Exagen (XGN) Price Target Increased by 17.39% to 15.74 - MSN
Visual trend scoring systems applied to Exagen Inc.Weekly Profit Analysis & High Conviction Buy Zone Alerts - newser.com
What to do if you’re stuck in Exagen Inc.Entry Point & Fast Moving Market Watchlists - newser.com
Short interest data insights for Exagen Inc.2025 Institutional Moves & Growth Focused Stock Pick Reports - newser.com
How supply shortages influence Exagen Inc. (E08A) stock2025 Stock Rankings & Real-Time Chart Breakout Alerts - newser.com
Can Exagen Inc. stock sustain revenue growth2025 Buyback Activity & Safe Capital Growth Stock Tips - newser.com
Canaccord Genuity reiterates Buy rating on Exagen stock, maintains $15 target By Investing.com - Investing.com South Africa
Canaccord Genuity reiterates Buy rating on Exagen stock, maintains $15 target - Investing.com India
The Market Doesn't Like What It Sees From Exagen Inc.'s (NASDAQ:XGN) Revenues Yet As Shares Tumble 27% - simplywall.st
Exagen Inc Stock (XGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.15%
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):